Literature DB >> 17785948

Heme as a magnificent molecule with multiple missions: heme determines its own fate and governs cellular homeostasis.

Kazumichi Furuyama1, Kiriko Kaneko, Patrick D Vargas.   

Abstract

Heme is a prosthetic group of various types of proteins, such as hemoglobin, myoglobin, cytochrome c, cytochrome p450, catalase and peroxidase. In addition, heme is involved in a variety of biological events by modulating the function or the state of hemoproteins. For example, protein synthesis is inhibited in erythroid cells under heme deficiency, as the consequence of the activation of heme-regulated inhibitor (HRI). Iron concentration in the cell is sensed and regulated by the heme-mediated oxidization and subsequent degradation of iron regulatory protein 2 (IRP2). Heme also binds to certain types of potassium channels, thereby inhibiting transmembrane K(+) currents. Importantly, heme determines its own fate; namely, heme regulates its synthesis and degradation through the feedback mechanisms, by which intracellular heme level is precisely maintained. Heme reduces heme synthesis by suppressing the expression of non-specific 5-aminolevulinate synthase (ALAS1) and stimulates heme breakdown by inducing heme oxygenase (HO)-1 expression. ALAS1 and HO-1 are the rate limiting enzymes in heme biosynthesis and catabolism, respectively. Accordingly, under the heme-rich condition, heme binds to cysteine-proline (CP) motifs of ALAS1 and those of transcriptional repressor Bach1, thereby leading to repression of mitochondrial transport of ALAS1 and induction of HO-1 transcription, respectively. Moreover, chemosensing functions of HO-2 containing CP motifs, another isozyme of HO, have been unveiled recently. In this review article, we summarize and update the pleiotropic effects of heme on various biological events and the regulatory network of heme biosynthesis and catabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17785948     DOI: 10.1620/tjem.213.1

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  65 in total

1.  Multiple regulatory mechanisms act in concert to control ferroportin expression and heme iron recycling by macrophages.

Authors:  Carole Beaumont
Journal:  Haematologica       Date:  2010-08       Impact factor: 9.941

2.  Kinetics and specificity of feline leukemia virus subgroup C receptor (FLVCR) export function and its dependence on hemopexin.

Authors:  Zhantao Yang; John D Philips; Raymond T Doty; Pablo Giraudi; J Donald Ostrow; Claudio Tiribelli; Ann Smith; Janis L Abkowitz
Journal:  J Biol Chem       Date:  2010-07-07       Impact factor: 5.157

3.  Measurement of Heme Synthesis Levels in Mammalian Cells.

Authors:  Jagmohan Hooda; Maksudul Alam; Li Zhang
Journal:  J Vis Exp       Date:  2015-07-09       Impact factor: 1.355

4.  FLVCR is necessary for erythroid maturation, may contribute to platelet maturation, but is dispensable for normal hematopoietic stem cell function.

Authors:  John C H Byon; Jing Chen; Raymond T Doty; Janis L Abkowitz
Journal:  Blood       Date:  2013-09-10       Impact factor: 22.113

5.  Proteomic analysis of saliva from partially and fully engorged adult female Rhipicephalus microplus (Acari: Ixodidae).

Authors:  Li-Li Feng; Lei Liu; Tian-Yin Cheng
Journal:  Exp Appl Acarol       Date:  2019-06-07       Impact factor: 2.132

Review 6.  Iron metabolism in erythroid cells and patients with congenital sideroblastic anemia.

Authors:  Kazumichi Furuyama; Kiriko Kaneko
Journal:  Int J Hematol       Date:  2017-11-14       Impact factor: 2.490

7.  Novel Mechanisms for Heme-dependent Degradation of ALAS1 Protein as a Component of Negative Feedback Regulation of Heme Biosynthesis.

Authors:  Yoshiko Kubota; Kazumi Nomura; Yasutake Katoh; Rina Yamashita; Kiriko Kaneko; Kazumichi Furuyama
Journal:  J Biol Chem       Date:  2016-08-05       Impact factor: 5.157

8.  Regulation of globin-heme balance in Diamond-Blackfan anemia by HSP70/GATA1.

Authors:  Sarah Rio; Marc Gastou; Narjesse Karboul; Raphaёl Derman; Thunwarat Suriyun; Hana Manceau; Thierry Leblanc; Jamel El Benna; Caroline Schmitt; Slim Azouzi; Jérome Larghéro; Zoubida Karim; Alejandra Macias-Garcia; Jane-Jane Chen; Olivier Hermine; Geneviève Courtois; Hervé Puy; Laurent Gouya; Narla Mohandas; Lydie Da Costa
Journal:  Blood       Date:  2019-01-30       Impact factor: 22.113

Review 9.  Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis.

Authors:  Achille Iolascon; Luigia De Falco; Carole Beaumont
Journal:  Haematologica       Date:  2009-01-30       Impact factor: 9.941

Review 10.  Cytochrome P450-mediated estrogen catabolism therapeutic avenues in epilepsy.

Authors:  Megha Gautam; Ganesh Thapa
Journal:  Acta Neurol Belg       Date:  2020-08-02       Impact factor: 2.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.